Back

Efficacy of inclisiran versus placebo in atherosclerotic cardiovascular disease: A systematic review and meta-analysis

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Beyond stents: digital health & pharmacotherapy impacting cardiovascular event rates Diabetes and the Heart EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Snigdha Baddepudi

Salisbury District Hospital, Salisbury (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Acute coronary occlusion in NSTEMI patients prevalence clinical characteristics and potential role of artificial intelligence
Mrs C. Stathakopoulou (Athens, GR)
Abstract Slides
Presentation thumbnail
Virtual assessment of microvascular resistance in young women with ST-Elevation Myocardial Infarction: a sub-analysis of the WAMIF registry
Doctor A. Boussema (Antibes, FR)
Abstract Slides
Presentation thumbnail
Association between pre-percutaneous coronary intervention lipoprotein (a) levels and angiographically confirmed in-stent restenosis: a systematic review and study-level meta-analysis
Doctor H. Rai (Dublin 7, IE)
Abstract Slides

Access the full session

Session thumbnail
Beyond stents: digital health & pharmacotherapy impacting cardiovascular event rates

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Congress Presentation
Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources